Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Dow
Colorcon
UBS
Queensland Health
US Army
Covington
US Department of Justice
Farmers Insurance
Federal Trade Commission

Generated: October 17, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,441,738

« Back to Dashboard

Summary for Patent: 5,441,738

Title: Process for improving a glycerolysed oil
Abstract:There is disclosed a process for improving a glycerolyzed oil. The oil is heated until any crystals which have formed have disappeared. Then the oil is crystallized by slow stirring for eight to seventy-two hours until an end of crystallization temperature of typically between 0.degree. and 15.degree. is reached. Finally the crystals which have formed are separated at the end of crystallization temperature. The process can be iterated at two successively lower end of crystallization temperatures.
Inventor(s): Klein; Jean-Marie (Feyzin, FR), Denis; Joel (Vourles, FR)
Assignee: Gattefosse SA (FR)
Application Number:08/081,355
Patent Claim Types:
see list of patent claims
Compound; Process;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,441,738

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France91 13715Oct 31, 1991
PCT Information
PCT FiledOctober 08, 1992PCT Application Number:PCT/FR92/00939
PCT Publication Date:May 13, 1993PCT Publication Number: WO93/09211

International Patent Family for Patent: 5,441,738

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada2096744► Subscribe
Germany69221848► Subscribe
European Patent Office0565673► Subscribe
Austria157391► Subscribe
France2683225► Subscribe
JapanH06504574► Subscribe
World Intellectual Property Organization (WIPO)9309211► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Daiichi Sankyo
Accenture
Julphar
Farmers Insurance
Dow
Queensland Health
Baxter
Argus Health
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot